ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
批准号:
2065191
负责人:
RUSSELL C JOHNSON
金额:
$15.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-06-01 至 1995-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Lyme disease is a tick-borne zoonosis. The major tick vectors of B.
burgdorferi are Ixodes species which lack host specificity. Control of
this disease through reducing the population of the rodent reservoirs and
larger mammalian hosts is impractical and may actually be
counterproductive. The widespread use of acaricides is of questionable
effectiveness and may have adverse environmental effects due to their lack
of specificity. A major step toward the control of Lyme disease in
domestic animals and humans is the development of a safe, effective and
relatively inexpensive vaccine. The number of cases of Lyme disease in
domestic animals and humans are increasing. Lyme disease is a complex
zoonosis maintained in natural foci between its tick vectors and animal
hosts. Recreational activities and living close to "nature" has resulted
in greater exposure to the tick vectors.
We have shown that hamsters can be protected from experimental infection by
B. burgdorferi by either passive or active immunization. This suggests the
feasibility of a Lyme disease vaccine for protecting both domestic animals
and humans from this disease. The identification and characterization of
the antigen(s) of B. burgdorferi responsible for immunity to infection will
facilitate the development of a safe and effective vaccine for Lyme
disease. In addition, these studies should increase our understanding of
the nature of the immune response to B burgdorferi.
The specific aims of this proposal are:
1) To identify immunotypes of B. burgdorferi in various geographical areas,
2) to identify the antigenic components(s) of B. burgdorferi associated
with immunotype specificity, 3) to characterize antigenic components(s) of
B. burgdorferi associated with immunotype specificity, 4) to investigate
interaction of immunotype specific antibody with B. burgdorferi and 5) to
develop oligonucleotide probes to identify the physical location of the
gene(s) that express the immunogenic components(s) of B. burgdorferi.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A guinea pig model for Lyme disease.
莱姆病豚鼠模型。
DOI:
10.1128/iai.61.11.4777-4784.1993
发表时间:
1993
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Sonnesyn,SW, Manivel,JC, Johnson,RC, Goodman,JL]
通讯作者:
Goodman,JL
DOI:
--
发表时间:
1992-07
期刊:
The American journal of pathology
影响因子:
--
作者:
[D. Defosse;P. Duray;R. C. Johnson]
通讯作者:
D. Defosse;P. Duray;R. C. Johnson
A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure.
严重心力衰竭患者伯氏疏螺旋体感染血清阳性率的前瞻性研究。
DOI:
10.1016/s0002-9149(99)80814-5
发表时间:
1995
期刊:
The American journal of cardiology
影响因子:
--
作者:
[Sonnesyn,SW, Diehl,SC, Johnson,RC, Kubo,SH, Goodman,JL]
通讯作者:
Goodman,JL
Cultivation of Borrelia burgdorferi from human tick bite sites: a guide to the risk of infection.
从人类蜱虫叮咬部位培养伯氏疏螺旋体:感染风险指南。
DOI:
10.1016/0190-9622(95)90123-x
发表时间:
1995
期刊:
Journal of the American Academy of Dermatology
影响因子:
13.8
作者:
[Berger,BW, Johnson,RC, Kodner,C, Coleman,L]
通讯作者:
Coleman,L
Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.
保护性免疫是由缺乏 OspA 和 OspB 的伯氏疏螺旋体突变体诱导的。
DOI:
10.1128/iai.61.12.5115-5122.1993
发表时间:
1993
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Hughes,CA, Engstrom,SM, Coleman,LA, Kodner,CB, Johnson,RC]
通讯作者:
Johnson,RC
HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.
-
批准号:6259331
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2001
-
负责人:RUSSELL C JOHNSON
-
依托单位:
HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.
-
批准号:6839928
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2001
-
负责人:RUSSELL C JOHNSON
-
依托单位:
HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.
-
批准号:6497381
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2001
-
负责人:RUSSELL C JOHNSON
-
依托单位:
HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.
-
批准号:6696260
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2001
-
负责人:RUSSELL C JOHNSON
-
依托单位:
HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.
-
批准号:6628076
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2001
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIMICROBIAL STUDIES OF B. BURGDOR FERI
-
批准号:3161988
-
项目类别:
-
资助金额:$16.62万
-
财政年份:1991
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIMICROBIAL STUDIES OF B. BURGDOR FERI
-
批准号:3161986
-
项目类别:
-
资助金额:$16.56万
-
财政年份:1991
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIMICROBIAL STUDIES OF B. BURGDOR FERI
-
批准号:3161987
-
项目类别:
-
资助金额:$15.98万
-
财政年份:1991
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
-
批准号:3144656
-
项目类别:
-
资助金额:$15.14万
-
财政年份:1990
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
-
批准号:3144657
-
项目类别:
-
资助金额:$14.73万
-
财政年份:1990
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
-
批准号:3144655
-
项目类别:
-
资助金额:$14.39万
-
财政年份:1990
-
负责人:RUSSELL C JOHNSON
-
依托单位:
ANTIGENIC/IMMUNOGENIC COMPONENTS--BORRELIA BURGDORFERI
-
批准号:3144653
-
项目类别:
-
资助金额:$14.27万
-
财政年份:1990
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE--STUDY OF THE ETIOLOGICAL AGENT
-
批准号:2078992
-
项目类别:
-
资助金额:$21.08万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE--ETIOLOGICAL AGENT
-
批准号:3156936
-
项目类别:
-
资助金额:$17.21万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE: STUDY OF THE ETIOLOGICAL AGENT
-
批准号:3153357
-
项目类别:
-
资助金额:$11.03万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE--ETIOLOGICAL AGENT
-
批准号:3156929
-
项目类别:
-
资助金额:$17.04万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE: STUDY OF THE ETIOLOGICAL AGENT
-
批准号:3156938
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE--STUDY OF THE ETIOLOGICAL AGENT
-
批准号:2607898
-
项目类别:
-
资助金额:$21.55万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE--STUDY OF THE ETIOLOGICAL AGENT
-
批准号:3156939
-
项目类别:
-
资助金额:$18.27万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
LYME DISEASE: STUDY OF THE ETIOLOGICAL AGENT
-
批准号:3156935
-
项目类别:
-
资助金额:$10.37万
-
财政年份:1984
-
负责人:RUSSELL C JOHNSON
-
依托单位:
海外基金